Patrik Pipkorn

Medicine & Life Sciences

1. 130-nm albumin-bound paclitaxel 22%
2. Albumin-Bound Paclitaxel 11%
3. azelastine 11%
4. Body Image 12%
5. Cancer Survivors 13%
6. Carcinoma 16%
7. Cetuximab 19%
8. Cisplatin 21%
9. Confidence Intervals 23%
10. Databases 32%
11. Deglutition 11%
12. Extranodal Extension 27%
13. Fistula 15%
14. Free Tissue Flaps 89%
15. Head 40%
16. Head and Neck Neoplasms 100%
17. Health Care Outcome Assessment 13%
18. Induction Chemotherapy 27%
19. Laryngectomy 18%
20. Laryngoscopes 14%
21. Librarians 13%
22. Lymph Nodes 18%
23. Margins of Excision 13%
24. Meta-Analysis 28%
25. Mouth 42%
26. Mouth Neoplasms 27%
27. Neck 53%
28. Neck Dissection 32%
29. Neoplasms 33%
30. Nose 13%
31. Odds Ratio 12%
32. Olopatadine Hydrochloride 12%
33. Oropharyngeal Neoplasms 88%
34. pembrolizumab 20%
35. Radiation 40%
36. Radiotherapy 44%
37. Recurrence 33%
38. Retrospective Studies 13%
39. Robotics 22%
40. Skull Base 41%
41. Smoking 20%
42. Soft Palate 22%
43. Squamous Cell Carcinoma 92%
44. Squamous Cell Carcinoma of Head and Neck 61%
45. Survival 70%
46. Systematic Reviews 70%
47. Therapeutics 19%
48. Tongue 12%
49. TP protocol 13%
50. Velopharyngeal Insufficiency 13%